Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Jachs

Showing results (71-80 of 118) with videos related to

Pageof 12
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|April 9, 2026
Prognostication of Liver Disease Patients via the WFUMB 'Rule-of-4' Algorithm Using SSI-2D-SWE-Based Liver Stiffness MeasurementChristian Sebesta, Georg Kramer, Nina Dominik, et al.
JHEP Reports : Innovation in Hepatology|October 24, 2024
Diagnostic and prognostic performance of the LiverRisk score in tertiary careGeorg Semmler, Lorenz Balcar, Benedikt Simbrunner, et al.
Wiener Klinische Wochenschrift|February 5, 2026
Chronic hepatitis D in Austria: high burden of cirrhosis and portal hypertension, IL28B C/C as unfavorable factor, increased systemic inflammation in decompensationMichael Schwarz, Caroline Schwarz, David J M Bauer, et al.
Journal of Hepatology|March 13, 2024
Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis deltaMathias Jachs, Lisa Sandmann, Lukas Hartl, et al.
Alimentary Pharmacology & Therapeutics|May 6, 2022
Response-guided long-term treatment of chronic hepatitis D patients with bulevirtide-results of a "real world" studyMathias Jachs, Caroline Schwarz, Marlene Panzer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 18, 2025
Neutrophil Extracellular Traps Are Not Linked to Decompensation, ACLF, or Death in Clinically Stable Patients With ACLDLorenz Balcar, Bernhard Scheiner, Benedikt Simbrunner, et al.
The American Journal of Gastroenterology|April 22, 2026
Sex does not impact the performance of non-invasive tests for clinically significant portal hypertension in cACLDPaula Höfinger, Helena Schluchter, Georg Semmler, et al.
Hepatology (Baltimore, Md.)|May 16, 2023
Etiological cure prevents further decompensation and mortality in patients with cirrhosis with ascites as the single first decompensating eventMarta Tonon, Lorenz Balcar, Georg Semmler, et al.
Journal of Hepatology|January 23, 2022
Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLDBernhard Scheiner, Lorenz Balcar, Rosa Johanna Nussbaumer, et al.
Alimentary Pharmacology & Therapeutics|November 6, 2025
Indocyanine Green Clearance Correlates With Biomarkers Reflecting Key Disease-Driving Mechanisms in Advanced Chronic Liver Disease and Predicts Acute-on-Chronic Liver Failure and DeathMathias Jachs, Tânia Carvalho, Benedikt Simbrunner, et al.
Pageof 12

Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
Liver International : Official Journal of the International Association for the Study of the Liver|April 9, 2026
Prognostication of Liver Disease Patients via the WFUMB 'Rule-of-4' Algorithm Using SSI-2D-SWE-Based Liver Stiffness MeasurementChristian Sebesta, Georg Kramer, Nina Dominik, et al.
JHEP Reports : Innovation in Hepatology|October 24, 2024
Diagnostic and prognostic performance of the LiverRisk score in tertiary careGeorg Semmler, Lorenz Balcar, Benedikt Simbrunner, et al.
Wiener Klinische Wochenschrift|February 5, 2026
Chronic hepatitis D in Austria: high burden of cirrhosis and portal hypertension, IL28B C/C as unfavorable factor, increased systemic inflammation in decompensationMichael Schwarz, Caroline Schwarz, David J M Bauer, et al.
Journal of Hepatology|March 13, 2024
Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis deltaMathias Jachs, Lisa Sandmann, Lukas Hartl, et al.
Alimentary Pharmacology & Therapeutics|May 6, 2022
Response-guided long-term treatment of chronic hepatitis D patients with bulevirtide-results of a "real world" studyMathias Jachs, Caroline Schwarz, Marlene Panzer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 18, 2025
Neutrophil Extracellular Traps Are Not Linked to Decompensation, ACLF, or Death in Clinically Stable Patients With ACLDLorenz Balcar, Bernhard Scheiner, Benedikt Simbrunner, et al.
The American Journal of Gastroenterology|April 22, 2026
Sex does not impact the performance of non-invasive tests for clinically significant portal hypertension in cACLDPaula Höfinger, Helena Schluchter, Georg Semmler, et al.
Hepatology (Baltimore, Md.)|May 16, 2023
Etiological cure prevents further decompensation and mortality in patients with cirrhosis with ascites as the single first decompensating eventMarta Tonon, Lorenz Balcar, Georg Semmler, et al.
Journal of Hepatology|January 23, 2022
Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLDBernhard Scheiner, Lorenz Balcar, Rosa Johanna Nussbaumer, et al.
Alimentary Pharmacology & Therapeutics|November 6, 2025
Indocyanine Green Clearance Correlates With Biomarkers Reflecting Key Disease-Driving Mechanisms in Advanced Chronic Liver Disease and Predicts Acute-on-Chronic Liver Failure and DeathMathias Jachs, Tânia Carvalho, Benedikt Simbrunner, et al.
Pageof 12